deepc
Driven by a desire to ensure precise diagnostics for all patients, deepc is on a mission to cut through the challenges of a crowded AI market and provide radiology teams with seamless access to an array of the best regulator-approved AI diagnostic tools. Its growing team of more than 40 employees with 20 different nationalities working in seven cities is dedicated to improving the AI user experience for radiologists while easing market access for AI software vendors.
Sector
Digital Medicine
Strategies
Digital Medicine
Status
Live
Website
deepc.ai
Related News
deepc closes Series A extension to accelerate global deployment of healthcare AI, bringing total funding to $30m
deepc acquires Osimis platform: strengthening the AI infrastructure for radiology at scale
deepc announces distribution agreement with Hyland Software to enhance medical imaging suite with cutting-edge AI technology
Brits call for tech revolution to tackle NHS wait times, deepc joins forces with BT
Digital Medicine pioneer, deepc, announces €12 million Series A round led by Sofinnova Partners
SofinnovaCapital
The Sofinnova Capital Strategy acts as a founding and lead investor in early-stage biopharma and medtech start-ups focusing on groundbreaking therapeutic technologies.
SofinnovaMD Start
The MD Start Strategy is Sofinnova’s in-house medtech accelerator. The team’s hands-on entrepreneurial expertise contributes to the platform's global leadership in company building.
SofinnovaCrossover
The Sofinnova Crossover Strategy supports ground-breaking innovations in later-stage biotech and medtech companies, enabling ambitious life sciences companies to reach their full potential.
SofinnovaIndustrial Biotech
Our Industrial Biotech Strategy seeks early-stage investments that will have a positive impact on sustainability in the chemicals, agriculture, food and materials sectors.
SofinnovaTelethon
The Sofinnova Telethon Strategy seeks early-stage projects to bring the best Italian science to the world stage.
SofinnovaDigital Medicine
The Sofinnova Digital Medicine Strategy backs early-stage startups at the intersection of biology, data and computation.
SofinnovaBiovelocita
The Sofinnova Biovelocita Strategy is dedicated entirely to the creation and acceleration of European biotech startups, in partnership with leading research organizations.